These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice. Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304 [TBL] [Abstract][Full Text] [Related]
8. Intraluminal prucalopride increases propulsive motor activities via luminal 5-HT Shokrollahi M; Chen JH; Huizinga JD Neurogastroenterol Motil; 2019 Oct; 31(10):e13598. PubMed ID: 31012538 [TBL] [Abstract][Full Text] [Related]
9. Epithelial 5-HT Mawe GM; Hurd M; Hennig GW; Lavoie B Adv Exp Med Biol; 2022; 1383():329-334. PubMed ID: 36587170 [TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats. Yu Y; Chen JH; Li H; Yang Z; Du X; Hong L; Liao H; Jiang L; Shi J; Zhao L; Tan S; Luo H; Huizinga JD Neurogastroenterol Motil; 2015 Jul; 27(7):914-28. PubMed ID: 25807879 [TBL] [Abstract][Full Text] [Related]
12. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study. Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968 [TBL] [Abstract][Full Text] [Related]
13. Use of prucalopride in adults with chronic idiopathic constipation. Vijayvargiya P; Camilleri M Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799 [No Abstract] [Full Text] [Related]
14. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon. Spohn SN; Bianco F; Scott RB; Keenan CM; Linton AA; O'Neill CH; Bonora E; Dicay M; Lavoie B; Wilcox RL; MacNaughton WK; De Giorgio R; Sharkey KA; Mawe GM Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173 [TBL] [Abstract][Full Text] [Related]
15. Effects and sites of action of a M1 receptor positive allosteric modulator on colonic motility in rats and dogs compared with 5-HT Tsukimi Y; Pustovit RV; Harrington AM; Garcia-Caraballo S; Brierley SM; Di Natale M; Molero JC; Furness JB Neurogastroenterol Motil; 2020 Aug; 32(8):e13866. PubMed ID: 32337809 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of prucalopride in adults and children with chronic constipation. Diederen K; Mugie SM; Benninga MA Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475 [TBL] [Abstract][Full Text] [Related]
17. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894 [TBL] [Abstract][Full Text] [Related]
19. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Alemi F; Poole DP; Chiu J; Schoonjans K; Cattaruzza F; Grider JR; Bunnett NW; Corvera CU Gastroenterology; 2013 Jan; 144(1):145-54. PubMed ID: 23041323 [TBL] [Abstract][Full Text] [Related]
20. The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats. Tong W; Kamiyama Y; Ridolfi TJ; Zietlow A; Zheng J; Kosinski L; Ludwig K; Takahashi T J Surg Res; 2011 Dec; 171(2):510-6. PubMed ID: 20691988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]